NNVC
NanoViricides (NNVC)
$
44About NanoViricides (NNVC)
NanoViricides, Inc. is a clinical stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
Details
Daily high
$1.45
Daily low
$1.42
Price at open
$1.45
52 Week High
$3.59
52 Week Low
$0.94
Market cap
23.5M
Dividend yield
0.00%
Volume
12,997
Avg. volume
122,139
P/E ratio
-2.09
NanoViricides News
Details
Daily high
$1.45
Daily low
$1.42
Price at open
$1.45
52 Week High
$3.59
52 Week Low
$0.94
Market cap
23.5M
Dividend yield
0.00%
Volume
12,997
Avg. volume
122,139
P/E ratio
-2.09